Research Analysts’ new coverage for Monday, July 6th:
Leerink Partners assumed coverage on shares of Avalo Therapeutics (NASDAQ:AVTX). They issued an outperform rating and a $38.00 target price on the stock.
Morgan Stanley initiated coverage on shares of ERock (NYSE:EROC). The firm issued an overweight rating and a $21.00 price target on the stock.
Wolfe Research initiated coverage on shares of ERock (NYSE:EROC). Wolfe Research issued an outperform rating and a $24.00 price target on the stock.
Bank of America Corporation began coverage on shares of ERock (NYSE:EROC). Bank of America Corporation issued a neutral rating and a $16.00 price target on the stock.
Guggenheim started coverage on shares of ERock (NYSE:EROC). The firm issued a buy rating and a $23.00 price target on the stock.
Barclays PLC started coverage on shares of ERock (NYSE:EROC). They issued an overweight rating and a $23.00 price target on the stock.
TD Cowen began coverage on shares of Forbright (NASDAQ:FRBT). TD Cowen issued a buy rating on the stock.
Barclays PLC started coverage on shares of Forbright (NASDAQ:FRBT). They issued an overweight rating and a $23.00 price target on the stock.
JPMorgan Chase & Co. started coverage on shares of Forbright (NASDAQ:FRBT). The firm issued a neutral rating and a $21.00 price target on the stock.
Siebert Williams Shank began coverage on shares of NRG Energy (NYSE:NRG). They issued a buy rating and a $184.00 price target on the stock.
Evercore Inc started coverage on shares of Parabilis Medicines (NASDAQ:PBLS). They issued an outperform rating on the stock.
Leerink Partners assumed coverage on shares of Parabilis Medicines (NASDAQ:PBLS). The firm issued an outperform rating and a $40.00 price target on the stock.
Bank of America Corporation initiated coverage on shares of Parabilis Medicines (NASDAQ:PBLS). Bank of America Corporation issued a buy rating and a $45.00 target price on the stock.
Wolfe Research started coverage on shares of Solaris Energy Infrastructure (NYSE:SEI). They issued an outperform rating and a $120.00 price target on the stock.
Lake Street Capital assumed coverage on shares of Oncology Institute (NASDAQ:TOI). They issued a buy rating and a $10.00 price target on the stock.
Stephens initiated coverage on shares of WhiteHawk Income (NYSE:WHK). They issued an overweight rating and a $33.00 price target on the stock.
Capital One Financial Corporation started coverage on shares of WhiteHawk Income (NYSE:WHK). They issued an overweight rating and a $32.00 target price on the stock.
Stifel Nicolaus started coverage on shares of WhiteHawk Income (NYSE:WHK). The firm issued a buy rating and a $30.00 price target on the stock.
JPMorgan Chase & Co. initiated coverage on shares of WhiteHawk Income (NYSE:WHK). They issued a neutral rating and a $28.00 price target on the stock.
JPMorgan Chase & Co. initiated coverage on shares of Wise Group (NASDAQ:WSE). They issued an overweight rating and a $17.50 price target on the stock.
Receive News & Ratings for Avalo Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalo Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
